Jupiter Neurosciences grants 100K stock options
Jupiter Neurosciences director Holger Weis received a grant of stock options covering 100,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Jupiter Neurosciences director Holger Weis received a grant of stock options covering 100,000 shares of common stock. The options have an exercise price of $0.2783 per share and expire on June 2, 2036. They were granted under the company’s 2025 Equity Incentive Plan and vest over three years starting on September 2, 2026, in equal quarterly installments, subject to continued service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 100,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date.
Key Figures
Key Terms
Stock Option financial
2025 Equity Incentive Plan financial
vest over three years financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Jupiter Neurosciences (JUNS) report for Holger Weis?
What is the exercise price of the new JUNS stock options granted to Holger Weis?
How do the Jupiter Neurosciences (JUNS) options granted to Holger Weis vest?
When do Holger Weis’s JUNS stock options expire?
How many Jupiter Neurosciences (JUNS) options does Holger Weis hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.